XPH vs. LBAY ETF Comparison

Comparison of SPDR S&P Pharmaceuticals ETF (XPH) to Leatherback Long/Short Alternative Yield ETF (LBAY)

XPH

SPDR S&P Pharmaceuticals ETF

XPH Description

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Grade (RS Rating)

Last Trade

$46.57

Average Daily Volume

60,972

Number of Holdings ^*

* may have additional holdings in another (foreign) market

LBAY

Leatherback Long/Short Alternative Yield ETF

LBAY Description

The investment seeks capital appreciation and income. The fund is an actively-managed ETF that seeks to achieve its investment objective by purchasing long positions in securities believed to provide sustainable shareholder yield (defined as dividends plus buybacks plus debt paydowns) and taking short positions in securities expected to decline in price. It will generally have net exposure of 75% - 110% long. The fund's long positions are generally expected to be comprised of equity securities or depositary receipts, although long positions may also include investment-grade corporate bonds and convertible bonds. It is non-diversified.

Grade (RS Rating)

Last Trade

$26.54

Average Daily Volume

2,703

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	XPH	LBAY
30 Days	0.69%	-3.39%
60 Days	6.08%	-3.50%
90 Days	5.92%	-2.55%
12 Months	28.75%	5.40%

2 Overlapping Holdings

	Symbol	Grade	Weight in XPH	Weight in LBAY	Overlap
	LLY	F	2.94%	-1.48%	-1.48%
	VTRS	A	3.73%	4.48%	3.73%

XPH Overweight 42 Positions Relative to LBAY

Symbol	Grade	Weight
CORT	B	4.96%
LBPH	A	4.12%
BMY	B	4.11%
ITCI	C	4.01%
JAZZ	B	3.94%
AXSM	B	3.59%
EWTX	C	3.42%
CTLT	B	3.41%
ELAN	D	3.35%
PRGO	B	3.35%
RPRX	D	3.18%
JNJ	D	3.17%
ZTS	D	3.15%
PFE	D	3.07%
MRK	F	2.93%
TARS	B	2.81%
OGN	D	2.58%
SAVA	D	2.57%
ARVN	D	2.53%
PBH	A	2.5%
SUPN	C	2.15%
AMPH	D	2.02%
PCRX	C	1.91%
LGND	B	1.77%
ANIP	F	1.54%
COLL	F	1.48%
OCUL	D	1.44%
AMRX	C	1.33%
MNMD	C	1.23%
HRMY	D	1.22%
WVE	C	1.17%
HROW	D	1.17%
INVA	D	0.98%
EYPT	F	0.94%
LQDA	D	0.89%
PLRX	F	0.87%
FULC	F	0.85%
ELVN	D	0.64%
NUVB	C	0.6%
EOLS	D	0.52%
PHAT	F	0.48%
XERS	B	0.46%

XPH Underweight 50 Positions Relative to LBAY

Symbol	Grade	Weight
LW	C	-4.96%
XOM	B	-4.78%
ORI	A	-4.77%
MO	A	-4.64%
NEM	D	-4.59%
BG	F	-4.57%
CMCSA	B	-4.57%
FIS	C	-4.54%
ZBH	C	-4.41%
AGNC	D	-4.41%
CVS	D	-4.36%
BERY	B	-4.14%
ICE	C	-4.08%
MTN	C	-3.91%
V	A	-3.89%
MDT	D	-3.86%
UNP	C	-3.77%
T	A	-3.64%
LHX	C	-3.59%
EBAY	D	-3.58%
MMM	D	-3.53%
AWK	D	-3.45%
BKNG	A	-3.37%
RIO	D	-3.28%
MSCI	C	-3.15%
APD	A	-3.11%
SPGI	C	-2.92%
PCH	D	-2.79%
DE	A	-2.68%
SHAK	C	--1.21%
DKS	C	--1.21%
BURL	A	--1.26%
SITE	D	--1.27%
RBLX	C	--1.29%
EQIX	A	--1.38%
TSLA	B	--1.45%
EVR	B	--1.46%
SF	B	--1.48%
DKNG	B	--1.49%
DLR	B	--1.51%
CVNA	B	--1.53%
AAPL	C	--1.53%
DAL	C	--1.53%
TOL	B	--1.54%
PLNT	A	--1.54%
AVGO	D	--1.54%
SQ	B	--1.56%
VRT	B	--1.63%
OLLI	D	--1.69%
DUOL	A	--1.85%

XPH: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major Drug Manufacturers - General Medical Distribution